Skip to main content

Posters

November 22, 2019
Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated significant efficacy in treatment of binge-eating disorder (BED). We now report an analysis from this study of the effect of dasotraline on body weight.
November 22, 2019
Background: In a previous flexible dose study, dasotraline, a long-acting dopamine/ norepinephrine reuptake inhibitor, demonstrated significant efficacy in the treatment of binge-eating disorder (BED). The aim of this confirmatory fixed-dose study was to evaluate efficacy and safety of dasotraline…
November 22, 2019
Background: In a previous study, dasotraline, a long-acting dopamine/norepinephrine reuptake inhibitor, demonstrated efficacy in the treatment of binge-eating disorder (BED). We now report an analysis from this study of the effect of dasotraline on binge-related obsessions and compulsions.
November 22, 2019
Individuals with binge eating disorder (BED) are at increased risk of developing symptoms of metabolic syndrome. In this retrospective cohort study, adult BED patients were identified using natural language processing of clinical notes sourced from the Optum electronic health record database from…
November 22, 2019
Individuals diagnosed with binge eating disorder (BED) are at higher risk of suicidality than those not diagnosed with BED. This study estimated the incidence (per 1000 person-years) of suicidal ideation and suicide attempts during a post-index date follow-up period (ie, the date of first BED…
November 22, 2019
There is a high comorbidity burden in adults diagnosed with binge eating disorder (BED). In this retrospective cohort study, adult BED patients were identified by using natural language processing (NLP) of clinical notes sourced from the Optum electronic health record database between January 1,…
March 02, 2019
Objective: To evaluate the efficacy of dasotraline in the treatment of secondary behavioral and psychological outcomes in patients with Binge-eating disorder (BED).
December 07, 2017
This poster was presented at the 30th annual  Psych Congress, held Sept. 16-19, 2017, in New Orleans, Louisiana. Background Binge eating disorder (BED) is the most common eating disorder with a US prevalence of 2.8%. This study evaluated dasotraline, a novel dopamine and norepinephrine…
November 29, 2017
The economic burden of binge-eating disorder (BED) in the US is not well quantified. This claims analysis compared healthcare utilization and costs of commercially insured enrollees with and without BED from the MarketScanВ Commercial Database.
January 27, 2016
This study reports changes in global wellbeing, as well as improvements in each of these five elements. Each of the eight trackable components (mood, anxiety, exercise, mindfulness, sleep, social connectedness, emotional eating, mental wellness) showed numeric improvements and all met statistical…
Back to Top